Related Experiment Video
Updated: May 24, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[Regional citrate anticoagulation: towards a first-choice treatment]
Santo Morabito1, Valentina Pistolesi, Alessandro Pierucci
1Universita' di Roma, Roma, Italy.
Regional citrate anticoagulation (RCA) offers a promising alternative to heparin for continuous renal replacement therapy (CRRT), reducing bleeding risks. Simplifying RCA protocols and automating delivery can enhance its adoption in critical care settings.
Area of Science:
- Nephrology
- Critical Care Medicine
- Pharmacology
Context:
- Continuous renal replacement therapy (CRRT) is standard for severe acute kidney injury in critically ill patients.
- Systemic anticoagulation, typically with heparin, is essential but carries significant bleeding risks.
- Alternative anticoagulation methods are needed to improve CRRT safety and efficacy.
Purpose:
- To evaluate regional citrate anticoagulation (RCA) as a safer and more effective alternative to heparin for CRRT.
- To highlight the benefits of RCA, including improved filter survival and reduced transfusion rates.
- To identify areas for improvement in RCA protocols to facilitate wider clinical adoption.
Summary:
- Regional citrate anticoagulation (RCA) effectively inhibits the coagulation cascade by chelating ionized calcium in the extracorporeal circuit.
- Studies show RCA offers superior filter longevity and decreases the need for blood transfusions compared to unfractionated heparin.
- Despite its benefits, RCA use remains limited; protocol simplification and automated delivery systems are key for future expansion.
Impact:
- RCA has the potential to significantly reduce bleeding complications and mortality associated with CRRT.
- Advancements in automated RCA delivery systems could streamline its implementation across diverse clinical scenarios.
- Wider adoption of RCA could improve patient outcomes and resource utilization in intensive care units.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
